Topics

Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments

08:00 EDT 13 Jun 2019 | Genetic Engineering News

Synlogic will use Ginkgo Bioworks’ cell programming platform to expand and further develop a pipeline of novel “living” medicines based on engineered probiotics, building upon a 1½-year-old collaboration launched by the companies.

The post Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments

NEXT ARTICLE

More From BioPortfolio on "Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...